Annovis Bio

Annovis Bio is a clinical-stage company developing drugs for neurodegeneration, such as Alzheimer’s Disease (AD), Parkinson’s Disease (PD), and other chronic neurodegenerative diseases.

Illustration for Fierces Chutes Ladders feature showing a blue city skyline with executives making career moves o
Biotech

Idorsia locks in new CEO after shakeup—Chutes & Ladders

Idorsia locks in new CEO after shakeup. NovaBridge nabs short-lived Idorsia chief as new CEO. Muna scoops former iTeos CEO as new leader.
topic report
rotten tomatoes tomato tomatoes

Fierce Biotech's Rotten Tomatoes of 2024

Dec 16, 2024 3:00am
success failure signposts

Annovis glosses over primary goal in pivotal Parkinson’s data

Jul 2, 2024 9:38am
Red graph decrease on black chalkboard

Annovis shares plummet 60% after muddled Alzheimer’s readout

Apr 29, 2024 11:45am